Multiorgan Quantitative T1 Mapping In Systemic Inflammation: Difference between revisions
Created page with "<!-- YOU ARE CREATING A NEW MEMBER SESSION PAGE. This is a template page that you can edit to suit your needs. The text within the '<!--' and '->' signs (including this text) is a comment and can be removed afterwards. Instructions: Fill in the following template with your information (replacing the dummy text after the '=' signs). Add a full session description after the template. --> {{Member Session | title= Multiorgan Quantitative T1 Mapping In Systemic Infl..." |
No edit summary |
||
| Line 13: | Line 13: | ||
{{Member Session | {{Member Session | ||
| title= Multiorgan Quantitative T1 Mapping In Systemic Inflammation | | title= Multiorgan Quantitative T1 Mapping In Systemic Inflammation | ||
| short_text= | | short_text= This session explores the technical considerations and clinical applications of quantitative T1 mapping for assessing systemic inflammation across multiple organs. We will examine how this MRI technique enables non-invasive tissue characterization by detecting inflammatory changes through alterations in T1 relaxation times. The session covers standardization of acquisition protocols, emerging analysis methods, and clinical validation studies demonstrating T1 mapping's utility in detecting and monitoring inflammatory processes in organs such as the heart, liver, pancreas and kidneys. Special attention will be given to the correlation between T1 values and inflammatory biomarkers, highlighting the technique's potential as a quantitative imaging biomarker for systemic inflammatory conditions. The session brings together experts in physics, radiology, and clinical medicine to provide a comprehensive perspective on this quantitative imaging tool. | ||
| duration= 60m | | duration= 60m | ||
| audience= Physicists, Radiologists | | audience= Physicists, Radiologists | ||
| Line 19: | Line 19: | ||
| Moderators_Confirmed= No | | Moderators_Confirmed= No | ||
| Speaker1= Matt Robson | | Speaker1= Matt Robson | ||
| Speaker1_Confirmed= | | Speaker1_Confirmed= Yes | ||
| Speaker2= | | Speaker2= Ilona Dekkers | ||
| Speaker2_Confirmed= No | | Speaker2_Confirmed= No | ||
| Speaker3= TBD | | Speaker3= TBD | ||
| Line 30: | Line 30: | ||
== Session description == | == Session description == | ||
This session will be about. | This session will be about quantitative T1 mapping for assessing systemic inflammation across multiple organs. The technique enables non-invasive tissue characterization for detecting and monitoring inflammatory processes in organs such as the heart, liver, pancreas and kidneys, with a focus on standardization, validation, and clinical implementation. | ||
The program will be the following: | The program will be the following: | ||
* Introduction ''( | * Introduction by Monika Dezortová ''(5 min)'': overview of the session goals and relevance of T1 mapping in systemic inflammation | ||
* Presentation by | * Presentation by Matt Robson ''(15 min)'': technical foundations and standardization of T1 mapping protocols across multiple organs | ||
* Presentation by | * Presentation by Ilona Dekkers ''(15 min)'': radiological perspective on T1 mapping analysis and interpretation in inflammatory conditions | ||
* Questions and Answers ''( | * Presentation by [Clinician TBD] ''(15 min)'': clinical applications and correlation with inflammatory biomarkers | ||
* Questions and Answers ''(10 min)'' | |||
Revision as of 15:11, 11 February 2025
Multiorgan Quantitative T1 Mapping In Systemic Inflammation
This session explores the technical considerations and clinical applications of quantitative T1 mapping for assessing systemic inflammation across multiple organs. We will examine how this MRI technique enables non-invasive tissue characterization by detecting inflammatory changes through alterations in T1 relaxation times. The session covers standardization of acquisition protocols, emerging analysis methods, and clinical validation studies demonstrating T1 mapping's utility in detecting and monitoring inflammatory processes in organs such as the heart, liver, pancreas and kidneys. Special attention will be given to the correlation between T1 values and inflammatory biomarkers, highlighting the technique's potential as a quantitative imaging biomarker for systemic inflammatory conditions. The session brings together experts in physics, radiology, and clinical medicine to provide a comprehensive perspective on this quantitative imaging tool.
| Session duration: | 60m |
| Intended audience: | Physicists, Radiologists |
| Moderators: | Monika Dezortová Ph.D. (Confirmed: No) |
| First Speaker: | Matt Robson (Confirmed: Yes) |
| Second Speaker: | Ilona Dekkers (Confirmed: No) |
| Third Speaker: | TBD (Confirmed: No) |
Session description
This session will be about quantitative T1 mapping for assessing systemic inflammation across multiple organs. The technique enables non-invasive tissue characterization for detecting and monitoring inflammatory processes in organs such as the heart, liver, pancreas and kidneys, with a focus on standardization, validation, and clinical implementation.
The program will be the following:
- Introduction by Monika Dezortová (5 min): overview of the session goals and relevance of T1 mapping in systemic inflammation
- Presentation by Matt Robson (15 min): technical foundations and standardization of T1 mapping protocols across multiple organs
- Presentation by Ilona Dekkers (15 min): radiological perspective on T1 mapping analysis and interpretation in inflammatory conditions
- Presentation by [Clinician TBD] (15 min): clinical applications and correlation with inflammatory biomarkers
- Questions and Answers (10 min)